Genpact CEO: M&A Bolstering Business Even as Stock Stays Flat

Global business consultants have seen their share prices stagnate partly due to geopolitical volatility, said NV 'Tiger' Tyagarajan, CEO of Genpact. Tyagarajan added that the secular trends are still positive for Genpact as international businesses attempt to streamline their processes. He said the company's purchase of life sciences player Pharmalink in the spring is already showing synergies and he expects a big return from Genpact's recent alliance with Automic software as business automation increases in importance. Finally, Tyagarajan said GE remains a great partner, even as Genpact continues to diversify its customer base.